Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.

Müller T, Welnic J, Woitalla D, Muhlack S.

Neurosci Lett. 2007 Jul 11;422(2):119-22. Epub 2007 Jun 8.

PMID:
17590511
2.

The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.

Müller T, Welnic J, Fuchs G, Baas H, Ebersbach G, Reichmann H.

J Neural Transm Suppl. 2006;(71):27-30.

PMID:
17447412
3.

Exercise improves efficacy of levodopa in patients with Parkinson's disease.

Muhlack S, Welnic J, Woitalla D, Müller T.

Mov Disord. 2007 Feb 15;22(3):427-30.

PMID:
17226855
4.

Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.

Müller T, Welnic J, Muhlack S.

J Neural Transm (Vienna). 2007 Mar;114(3):347-50. Epub 2006 Aug 24.

PMID:
16932991
5.

Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson disease.

Müller T, Lang UE, Muhlack S, Welnic J, Hellweg R.

Clin Neuropharmacol. 2005 Sep-Oct;28(5):238-40.

PMID:
16239764
6.

Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.

Muhlack S, Woitalla D, Welnic J, Twiehaus S, Przuntek H, Müller T.

Neurosci Lett. 2004 Jun 17;363(3):284-7.

PMID:
15182961

Supplemental Content

Loading ...
Support Center